טוען...
PELP1: A novel therapeutic target for hormonal cancers
Recent studies implicate the estrogen receptor (ER) coregulator proline-, glutamic acid-, and leucine-rich protein (PELP) 1 as playing critical roles in ER-genomic, ER-nongenomic and ER-signaling cross talk with growth factor signaling pathways. PELP1 expression is deregulated in hormonal cancers an...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2997573/ https://ncbi.nlm.nih.gov/pubmed/20014005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iub.287 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|